The common adverse reactions of GLP-1R agonists include gastrointestinal reactions, mainly loss of appetite, nausea, vomiting, diarrhea, abdominal pain, etc., primarily mild or moderate
Gastroenterology 2024;167(2):402404.e3
The fact that covering GLP-1s under Medicare Part D for authorized uses is already making a mark on total Part D program spending could be a sign of even higher spending to come as Part D plans are now able to cover Wegovy for its heart health benefits, as other uses for GLP-1s are approved, and as policymakers consider legislation that would authorize Medicare to cover obesity drugs
Other weight-loss drugs were mentioned in just a handful of cases
Talk to a Heally doctor about switching Changing your telehealth provider If you are already on a GLP-1 medication but your current provider is hard to reach, slow with refills, or not offering the telehealth experience you need, transferring your care to Heally is straightforward
enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC) nave to second-generation antiandrogens